Watchlist Price Alert

TransMedics Group Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

111.39

18.19 (19.52%)

At close: May 09, 2025, 3:59 PM

111.58

0.17%

After-hours: May 09, 2025, 05:58 PM EDT

19.52% (1D)

Bid	111.49
Market Cap	3.77B
Revenue (ttm)	441.54M
Net Income (ttm)	35.46M
EPS (ttm)	1.07
PE Ratio (ttm)	104.11
Forward PE	42.62
Analyst	Buy

Ask	111.99
Volume	4,274,334
Avg. Volume (20D)	1,244,597.3
Open	115.46
Previous Close	93.20
Day's Range	108.84 - 120.93
52-Week Range	55.00 - 177.37
Beta	1.90

About TMDX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol TMDX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TMDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

TransMedics has released their quartely earnings on May 8, 2025:

Revenue of $143.54M exceeds estimates by $20.15M, with 48.21% YoY growth.

EPS of 0.7 exceeds estimates by 0.46, with 100.00% YoY growth.

Why Price Moved

23 hours ago New

TransMedics Group shares are trading higher after ... Unlock content with Pro Subscription

14 hours ago New

-2.72%

TransMedics Group shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates.

News

23 hours ago · zacks.com

TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down

Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.

1 day ago · fool.com

Why TransMedics Stock Is Skyrocketing Today

Shares of next-generation transplant technology platform TransMedics (TMDX 21.72%) were up 21% as of noon ET on Friday, according to data provided by S&P Global Market Intelligence.

15 hours ago · seekingalpha.com

TransMedics: Exceptional Q1 Undermines The Short Narrative

TransMedics reported extremely strong Q1 results, alleviating concerns from a weak Q3 2024 and a short attack in January. The company continues to expand its logistics capabilities and should see a bo...

14 hours ago · seekingalpha.com

TransMedics Group, Inc. (TMDX) Q1 2025 Earnings Call Transcript

TransMedics Group, Inc. (NASDAQ:TMDX ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group, Investor Relations Waleed Hassanein - President & Ch...

1 day ago · zacks.com

Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics

The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street esti...

1 day ago · zacks.com

TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates

TransMedics (TMDX) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.35 per share a year ago.

1 day ago · accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") ...

4 days ago · marketbeat.com

3 Mid-Cap Medical Stocks Outperforming the Market

While major market indexes like the S&P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several medical and biotec...

3 days ago · accessnewswire.com

TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") ...

4 days ago · zacks.com

Insights Into TransMedics (TMDX) Q1: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of TransMedics (TMDX) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for ...

Load More News